Keck Medicine of USC Huntington Beach — Huntington Beach, California

Public research footprint of Keck Medicine of USC Huntington Beach, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Most-studied conditions

Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear… · Stage I Pancreatic Neuroendocrine Tumor AJCC v8 · Testicular Non-Seminomatous Germ Cell Tumor · Low Grade Fallopian Tube Serous Adenocarcinoma

Recently updated registry entries

NCT02194738 — Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That… (Active Not Recruiting)
NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT03698019 — A Study to Compare the Administration of Pembrolizumab After Surgery Versus… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Keck Medicine of USC Huntington Beach?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.